A novel cationic liposome nanocarrier, having interesting performance in topical drug delivery, is here presented and evaluated for its features. Two penetration enhancers, namely monoolein and lauroylcholine chloride, are combined to rapidly formulate (15 min) a cationic liposome nanostructure endowed of excellent stability (>6 months) and skin penetration ability, along with low short-term cytotoxicity, as evaluated via the MTT test. Cytotoxicity tests and lipid droplet analysis give a strong indication that monoolein and lauroylcholine synergistically endanger long-term cells viability. The physicochemical features, investigated through SAXS, DLS, and cryo-TEM techniques, reveal that the nanostructure is retained after loading with diclofenac in its acid (hydrophobic) form. The drug release performances are studied using intact newborn pig skin. Analysis of the different skin strata proves that the drug mainly accumulates into the viable epidermis with almost no deposition into the derma. Indeed, the flux of the drug across the skin is exceptionally low, with only 1% release after 24 h. These results validate the use of this novel formulation for topical drug release when the delivery to the systemic circulation should be avoided. Liposomes based on monoolein and lauroylcholine chloride are taken up by 3T3 fibroblasts. Liposome treatment induces lipid droplets formation as shown by Nile Red staining. Green fluorescent lipid droplets become intense 4 h after the treatment. Nuclear staining with Hoechst 33258 revealed nuclear morphology of viable cells.

Physicochemical, cytotoxic, and dermal release features of a novel cationic liposome nanocarrier

FALCHI, ANGELA MARIA;LAMPIS, SANDRINA;SINICO, CHIARA;MANCA, MARIA LETIZIA;MURGIA, SERGIO;MONDUZZI, MAURA
2013-01-01

Abstract

A novel cationic liposome nanocarrier, having interesting performance in topical drug delivery, is here presented and evaluated for its features. Two penetration enhancers, namely monoolein and lauroylcholine chloride, are combined to rapidly formulate (15 min) a cationic liposome nanostructure endowed of excellent stability (>6 months) and skin penetration ability, along with low short-term cytotoxicity, as evaluated via the MTT test. Cytotoxicity tests and lipid droplet analysis give a strong indication that monoolein and lauroylcholine synergistically endanger long-term cells viability. The physicochemical features, investigated through SAXS, DLS, and cryo-TEM techniques, reveal that the nanostructure is retained after loading with diclofenac in its acid (hydrophobic) form. The drug release performances are studied using intact newborn pig skin. Analysis of the different skin strata proves that the drug mainly accumulates into the viable epidermis with almost no deposition into the derma. Indeed, the flux of the drug across the skin is exceptionally low, with only 1% release after 24 h. These results validate the use of this novel formulation for topical drug release when the delivery to the systemic circulation should be avoided. Liposomes based on monoolein and lauroylcholine chloride are taken up by 3T3 fibroblasts. Liposome treatment induces lipid droplets formation as shown by Nile Red staining. Green fluorescent lipid droplets become intense 4 h after the treatment. Nuclear staining with Hoechst 33258 revealed nuclear morphology of viable cells.
File in questo prodotto:
File Dimensione Formato  
Carboni AdvHealthcareMater 2013.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 1.14 MB
Formato Adobe PDF
1.14 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/88349
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 38
social impact